
Liquidity, historical trends, and peer comparisons.
According to Fulgent Genetics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 6.34. This represents a change of 0.85% compared to the average of 6.28 of the last 4 quarters.
The mean historical Current Ratio of Fulgent Genetics, Inc. over the last ten years is 9.08. The current 6.34 Current Ratio has changed -30.19% with respect to the historical average. Over the past ten years (40 quarters), FLGT's Current Ratio was at its highest in in the September 2018 quarter at 18.95. The Current Ratio was at its lowest in in the September 2016 quarter at 2.32.
Average
9.08
Median
7.04
Minimum
4.02
Maximum
15.80
Discovering the peaks and valleys of Fulgent Genetics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 234.19%
Maximum Annual Current Ratio = 15.80
Minimum Annual Increase = -59.59%
Minimum Annual Current Ratio = 4.02
| Year | Current Ratio | Change |
|---|---|---|
| 2025 | 6.48 | 33.58% |
| 2024 | 4.85 | -30.26% |
| 2023 | 6.96 | -2.40% |
| 2022 | 7.13 | 22.63% |
| 2021 | 5.81 | 44.40% |
| 2020 | 4.02 | -59.59% |
| 2019 | 9.96 | -36.97% |
| 2018 | 15.80 | 1.87% |
| 2017 | 15.51 | 8.67% |
| 2016 | 14.27 | 234.19% |
The current Current Ratio of Fulgent Genetics, Inc. (FLGT) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
6.09
5-year avg
6.24
10-year avg
9.08
Fulgent Genetics, Inc.’s Current Ratio is greater than NeoGenomics, Inc. (3.53), greater than Myriad Genetics, Inc. (1.98), greater than Guardant Health, Inc. (4.03), greater than Natera, Inc. (3.00), less than BillionToOne, Inc. (11.25), greater than Personalis, Inc. (5.28), greater than GeneDx Holdings Corp. (3.30), less than Freenome, Inc. (0),
| Company | Current Ratio | Market cap |
|---|---|---|
| 3.53 | $2.23B | |
| 1.98 | $575.81M | |
| 4.03 | $22.62B | |
| 3.00 | $56.36B | |
| 11.25 | $5.37B | |
| 5.28 | $1.69B | |
| 3.30 | $2.07B | |
| 0 | $92.18M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Fulgent Genetics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Fulgent Genetics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Fulgent Genetics, Inc.'s Current Ratio?
How is the Current Ratio calculated for Fulgent Genetics, Inc. (FLGT)?
What is the highest Current Ratio for Fulgent Genetics, Inc. (FLGT)?
What is the 3-year average Current Ratio for Fulgent Genetics, Inc. (FLGT)?
What is the 5-year average Current Ratio for Fulgent Genetics, Inc. (FLGT)?
How does the current Current Ratio for Fulgent Genetics, Inc. (FLGT) compare to its historical average?